GlaxoSmithKline Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Combination vaccines

Registered for primary immunisation in infants aged 6 weeks–12 months.

Hib-MenC — combination Haemophilus influenzae type b and meningococcal serogroup C–tetanus toxoid conjugate vaccine

Lyophilised powder in a monodose vial with a pre-filled diluent syringe.

Each 0.5 mL reconstituted dose contains:

  • 5 µg Hib capsular polysaccharide (polyribosyl-ribitol-phosphate) conjugated to 12.5 µg tetanus toxoid (PRP-T)
  • 5 µg Neisseria meningitidis serogroup C polysaccharide conjugated to 5 µg tetanus toxoid
  • traces of trometamol

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018


polyribosylribitol phosphate